Showing 31-40 of 805 results for "".
Modern Management of Vitreous Opacities: Surgical Considerations
https://modernod.com/podcasts/the-mod-pod/vitreous-opacities-surgical-considerations/36821/How have innovations in surgical instrumentation created an environment in which surgeons are more comfortable performing vitrectomy for vitreous opacities? In the final episode of the miniseries “Modern Management of Vitreous Opacities,” a panel comprised of Walt Whitley, OD, MBA; Alison Early, MD;Modern Management of Vitreous Opacities: Examination and Referral
https://modernod.com/podcasts/the-mod-pod/vitreous-opacities-examination-and-referral/36820/Which elements of examination must optometrists perfect in order to provide an effective referral for patients with vitreous opacities? On this second episode of the miniseries “Modern Management of Vitreous Opacities,” the panel comprised of Walt Whitley, OD, MBA; Alison Early, MD; John Kitchens, MReferral Network Breakdown
https://modernod.com/mod-issues/2019-mar/referral-network-breakdown/39052/The two most common types of communication issues between collaborating ODs and MDs and how to set them straight.[Genetics and Eyecare Today] How CXL and Genetic Testing Fit Into the Keratoconus Game Plan
https://modernod.com/podcasts/the-mod-pod/genetics-and-eyecare-today-how-cxl-and-genetic-testing-fit-into-the-keratoconus-game-plan/36816/The season finale of The MOD Pod’s mini series Genetics and Eyecare Today features Nicole Fram, MD, and Melissa Barnett, OD, FAAO, FSLS, FBCLA. Dr. Fram explains what corneal collagen crosslinking is and shares her protocol for administering the therapy. She also describes the typical situation in wFirst Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesFirst Robotic Cataract Surgery Performed
https://modernod.com/podcasts/eyewire-news-the-podcast/first-robotic-cataract-surgery-performed/39875/Uday Devgan, MD, shares his experience performing the world’s first robotic cataract surgery; Konan Medical receives CE Mark for its objectiveFIELD Analyzer perimetry device; and Biotech Healthcare launches a new full visual range EDOF IOL. Learn more about your ad choices. Visit megaphone.fm/adchoAlcon Acquires LumiThera
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-lumithera/37092/Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management. Learn more about your ad choices. Visit megaphone.fm/adchoicesAn Interview With the Inventor of Rinsada
https://modernod.com/podcasts/to-the-point/an-interview-with-the-inventor-of-rinsada/36934/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by retina specialist Srinivas Kondapalli, MD, who developed the Rinsada Irrigating Lid Retractor, which effectively cleanses the conjunctival fornix, palpebral conjunctiva, and bulbar conjunctiva.Case Studies in Treating Ocular Surface Disease: Season 5
https://modernod.com/podcasts/the-mod-pod/case-studies-in-treating-ocular-surface-disease-season-5/36830/The newest season includes a new expert panel featuring Jackie Garlich, OD, FAAO; Justin Schweitzer, OD, FAAO; and William B. Trattler, MD, as they share unique cases of meibomian gland dysfunction, neurotrophic keratitis, and the impact of ocular surface disease on cataract surgery planning.Case Studies in Treating Ocular Surface Disease: Season 4
https://modernod.com/podcasts/the-mod-pod/case-studies-in-treating-ocular-surface-disease-season-4/36826/Don’t miss this season in which our new expert panel of Leslie O’Dell, OD, FAAO; Emilie Seitz, OD; and Ivan Mac, MD, MBA, discuss unique and challenging cases involving ocular surface disease and dry eye.